Seminar with the CMDE on New IVD and NGS Technologies

2016-08-30 | Beijing, Shanghai

Seminar with the CMDE on New IVD and NGS Technologies

High-level researchers from the R&D centres of member companies presented on new technologies for detection and assessment of treatment results of cancer. The presentations focussed on 

- biomarkes in oncology

- Liquid Biopsy Technologies

- NGS-based Test and Services

China has become the country with most cancer patients in the world. Manufactures are encouraged to strengthen R&D and bring the newest products on the Chinese market. At the same time regulators should accelarate market approval to avoid delayed access to life-saving technologies for Chinese patients.